Posts Tagged ‘CMS’

No, the Door Is Not Closed on Obesity Medicines at CMS

April 9, 2025 — As everyone digests the news that CMS has chosen not to expand coverage of obesity medicines under Medicare and Medicaid “at this time,” it is becoming clear the door is not closed. HHS told Bndpoints News: “CMS may consider future policy options for obesity medications pending further review of both the potential benefits of these […]

CMS Says “Not Yet” On Medicare Coverage for Obesity

April 5, 2025 — We should be used to this by now. For years, we’ve urged policymakers to find a way out of the box that has Medicare denying coverage for obesity. This time, it seemed we were close. But close doesn’t count. Late yesterday, the Trump administration said “CMS is not finalizing” provisions of a proposed rule that […]

An Easy Win on Obesity for a New Administration

January 13, 2025 — Many years of working on obesity has taught us one thing. Success does not come easily. And yet in this new year, it appears that the new administration in Washington will have an opportunity to claim an easy win on obesity. CMS has a new rule for obesity drugs that can become final in the […]

Lend Your Support to CMS for Better Access to Obesity Medicines

January 9, 2025 — The docket is open for you to lend your support until January 27. The Center for Medicare and Medicaid Services (CMS) is proposing to open up access to obesity medicines in both of the programs they oversee. This is something that we – with virtually every advocate for obesity care – have been seeking for […]

Arugulazempic: The Coming Word Salad of Health Policy

January 3, 2025 — “Yes, by all means, let’s eat more arugula. But let’s not turn our back on the role of human ingenuity in making America healthier.” This is how Rich Lowry, Editor in Chief of the National Review, tried this week to make sense of the coming salad of health policy that we will call arugulazempic. Give […]

Five Stories That Defined 2024 in Obesity and Health

December 16, 2024 — The closing days of 2024 give us a moment to reflect on the stories that defined this year in obesity and health. It’s been a big year, with no shortage of news on this subject. But the major themes stand out very clearly. Health Outcomes Beyond Weight Loss This was the year that objective evidence […]

Breaking: CMS Proposes Opening Medicare to Obesity Meds

November 26, 2024 — Well, this is exciting. The news just flashed across our screen that the outgoing Biden administration is proposing to open up Medicare and Medicaid to coverage for obesity meds. Chiquita Brooks-LaSure, administrator of the Centers Medicare and Medicaid Services, said: “We don’t want to see people having to wait until they have these additional diseases […]

Opening Medicare to Semaglutide for Obesity and Heart Disease

March 22, 2024 — This is a striking change. Until now, the steadfast refusal of CMS to allow coverage of any obesity medicine by Medicare has been unwavering. Then two weeks ago, FDA granted a new indication for semaglutide for persons with both heart disease and obesity to prevent heart attacks, strokes, and deaths. Now CMS says it’s A-OK […]

Botox, Knee Replacements, and Obesity Meds

October 3, 2022 — Health insurers, including Medicare, are regarding obesity meds like Botox Cosmetic, when they should be thinking of them more like a knee replacement. This observation, from a report by Jamy Lee in MarketWatch, sums up the challenge for people seeking obesity care in a health system that pays for the complications of untreated obesity, but […]

House Appropriations Calls for Obesity Meds in Medicare

June 30, 2022 — Okay, this is hardly a final victory, but it sure does feel good. The U.S. House Appropriations Committee released its legislative report on funding for Health and Human Services. It’s a beastly 623 page document that goes over all the spending priorities for the department. However, if you dig deep into it, there’s a paragraph […]